Tibor Keler, Senior VP & CSO at Celldex Therapeutics, Inc. (CLDX), bought 5,000 shares at $2.50 ($13K) on 2011-08-11, disclosed to the SEC on 2011-08-11.
Open-market purchase of $12k CLDX by Senior VP & CSO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CLDX | BUY | 2018-06-18 | $10K | — | Filing → |
| CLDX | BUY | 2016-09-06 | $10K | — | Filing → |
| CLDX | BUY | 2010-09-13 | $18K | — | Filing → |